Search Results - "Crosby, Erika"

Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection by Crosby, Erika J, Goldschmidt, Michael H, Wherry, E John, Scott, Phillip

“…One of the hallmarks of adaptive immunity is the development of a long-term pathogen specific memory response. While persistent memory T cells certainly impact…”
Get full text

Beyond Neoantigens: Antigens Derived from Tumor Drivers as Cancer Vaccine Targets by Crosby, Erika J, Hartman, Zachary C, Lyerly, H Kim

“…A vaccine targeting HER2, a nonmutated but overexpressed tumor antigen, readily primed T cells for ex vivo expansion and adoptive transfer with minimal…”
Get full text

Cancer vaccine strategies using self-replicating RNA viral platforms by Dailey, Gabrielle P., Crosby, Erika J., Hartman, Zachary C.

“…The development and success of RNA-based vaccines targeting SARS-CoV-2 has awakened new interest in utilizing RNA vaccines against cancer, particularly in the…”
Get full text

Clinical trials of self-replicating RNA-based cancer vaccines by Morse, Michael A., Crosby, Erika J., Force, Jeremy, Osada, Takuya, Hobeika, Amy C., Hartman, Zachary C., Berglund, Peter, Smith, Jonathan, Lyerly, H. Kim

“…Therapeutic cancer vaccines, designed to activate immune effectors against tumor antigens, utilize a number of different platforms for antigen delivery. Among…”
Get full text

Vaccine-Induced Memory CD8 + T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study by Crosby, Erika J, Gwin, William, Blackwell, Kimberly, Marcom, Paul K, Chang, Serena, Maecker, Holden T, Broadwater, Gloria, Hyslop, Terry, Kim, Sungjin, Rogatko, Andre, Lubkov, Veronica, Snyder, Joshua C, Osada, Takuya, Hobeika, Amy C, Morse, Michael A, Lyerly, H Kim, Hartman, Zachary C

“…Immune-based therapy for metastatic breast cancer has had limited success, particularly in molecular subtypes with low somatic mutations rates. Strategies to…”
Get full text

Intratumoral Plasmid IL12 Expands CD8 + T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy by Telli, Melinda L, Nagata, Hiroshi, Wapnir, Irene, Acharya, Chaitanya R, Zablotsky, Kaitlin, Fox, Bernard A, Bifulco, Carlo B, Jensen, Shawn M, Ballesteros-Merino, Carmen, Le, Mai Hope, Pierce, Robert H, Browning, Erica, Hermiz, Reneta, Svenson, Lauren, Bannavong, Donna, Jaffe, Kim, Sell, Jendy, Foerter, Kellie Malloy, Canton, David A, Twitty, Christopher G, Osada, Takuya, Lyerly, H Kim, Crosby, Erika J

“…Triple-negative breast cancer (TNBC) is an aggressive disease with limited therapeutic options. Antibodies targeting programmed cell death protein 1…”
Get full text

Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major by Crosby, Erika J, Clark, Megan, Novais, Fernanda O, Wherry, E John, Scott, Phillip

“…Leishmaniasis is a significant neglected tropical disease that is associated with a wide range of clinical presentations and a lifelong persistent infection…”
Get full text

Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer by Crosby, Erika J, Acharya, Chaitanya R, Haddad, Anthony-Fayez, Rabiola, Christopher A, Lei, Gangjun, Wei, Jun-Ping, Yang, Xiao-Yi, Wang, Tao, Liu, Cong-Xiao, Wagner, Kay U, Muller, William J, Chodosh, Lewis A, Broadwater, Gloria, Hyslop, Terry, Shepherd, Jonathan H, Hollern, Daniel P, He, Xiaping, Perou, Charles M, Chai, Shengjie, Ashby, Benjamin K, Vincent, Benjamin G, Snyder, Joshua C, Force, Jeremy, Morse, Michael A, Lyerly, Herbert K, Hartman, Zachary C

“…Despite promising advances in breast cancer immunotherapy, augmenting T-cell infiltration has remained a significant challenge. Although neither individual…”
Get full text

Effector T Cell Egress via Afferent Lymph Modulates Local Tissue Inflammation by Gómez, Daniela, Diehl, Malissa C, Crosby, Erika J, Weinkopff, Tiffany, Debes, Gudrun F

“…Memory/effector T cells recirculate through extralymphoid tissues by entering from blood and egressing via afferent lymph. Although T cell entry into effector…”
Get full text

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors by Crosby, Erika J., Wei, Junping, Yang, Xiao Yi, Lei, Gangjun, Wang, Tao, Liu, Cong-Xiao, Agarwal, Pankaj, Korman, Alan J., Morse, Michael A., Gouin, Kenneth, Knott, Simon R. V., Lyerly, H. Kim, Hartman, Zachary C.

“…Triple-negative breast cancer (TNBC) is an aggressive and molecularly diverse breast cancer subtype typified by the presence of p53 mutations (∼80%), elevated…”
Get full text

Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity by Abe, Shinya, Nagata, Hiroshi, Crosby, Erika J, Inoue, Yoshiyuki, Kaneko, Kensuke, Liu, Cong-Xiao, Yang, Xiao, Wang, Tao, Acharya, Chaitanya R, Agarwal, Pankaj, Snyder, Joshua, Gwin, William, Morse, Michael A, Zhong, Pei, Lyerly, Herbert Kim, Osada, Takuya

“…BackgroundDespite multimodal adjuvant management with radiotherapy, chemotherapy and hormonal therapies, most surgically resected primary breast cancers…”
Get full text

CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis by Tsao, Li-Chung, Crosby, Erika J, Trotter, Timothy N, Agarwal, Pankaj, Hwang, Bin-Jin, Acharya, Chaitanya, Shuptrine, Casey W, Wang, Tao, Wei, Junping, Yang, Xiao, Lei, Gangjun, Liu, Cong-Xiao, Rabiola, Christopher A, Chodosh, Lewis A, Muller, William J, Lyerly, Herbert Kim, Hartman, Zachary C

“…The HER2-specific monoclonal antibody (mAb), trastuzumab, has been the mainstay of therapy for HER2+ breast cancer (BC) for approximately 20 years. However,…”
Get full text

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors by Crosby, Erika J, Lyerly, H Kim, Hartman, Zachary C

Get full text

Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer by Dailey, Gabrielle P, Rabiola, Christopher A, Lei, Gangjun, Wei, Junping, Yang, Xiao-Yi, Wang, Tao, Liu, Cong-Xiao, Gajda, Melissa, Hobeika, Amy C, Summers, Amanda, Marek, Robert D, Morse, Michael A, Lyerly, Herbert K, Crosby, Erika J, Hartman, Zachary C

“…ER+ breast cancers (BC) are characterized by the elevated expression and signaling of estrogen receptor alpha ( , which renders them sensitive to…”
Get full text

HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study by Osada, Takuya, Crosby, Erika J, Kaneko, Kensuke, Snyder, Joshua C, Ginzel, Joshua D, Acharya, Chaitanya R, Yang, Xiao-Yi, Polascik, Thomas J, Spasojevic, Ivan, Nelson, Rendon C, Hobeika, Amy, Hartman, Zachary C, Neckers, Leonard M, Rogatko, Andre, Hughes, Philip F, Huang, Jiaoti, Morse, Michael A, Haystead, Timothy, Lyerly, H Kim

“…A noninvasive test to discriminate indolent prostate cancers from lethal ones would focus treatment where necessary while reducing overtreatment. We exploited…”
Get full text

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio by Crosby, Erika J, Hobeika, Amy C, Niedzwiecki, Donna, Rushing, Christel, Hsu, David, Berglund, Peter, Smith, Jonathan, Osada, Takuya, Gwin III, William R, Hartman, Zachary C, Morse, Michael A, Lyerly, Herbert Kim

“…BackgroundThere remains a significant need to eliminate the risk of recurrence of resected cancers. Cancer vaccines are well tolerated and activate…”
Get full text

HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase by Ginzel, Joshua D, Acharya, Chaitanya R, Lubkov, Veronica, Mori, Hidetoshi, Boone, Peter G, Rochelle, Lauren K, Roberts, Wendy L, Everitt, Jeffrey I, Hartman, Zachary C, Crosby, Erika J, Barak, Lawrence S, Caron, Marc G, Chen, Jane Q, Hubbard, Neil E, Cardiff, Robert D, Borowsky, Alexander D, Lyerly, H Kim, Snyder, Joshua C

“…HER2-positive breast cancers are among the most heterogeneous breast cancer subtypes. The early amplification of HER2 and its known oncogenic isoforms provide…”
Get full text

Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis by Tsao, Li-Chung, Crosby, Erika J, Trotter, Timothy N, Wei, Junping, Wang, Tao, Yang, Xiao, Summers, Amanda N, Lei, Gangjun, Rabiola, Christopher A, Chodosh, Lewis A, Muller, William J, Lyerly, Herbert Kim, Hartman, Zachary C

“…Two HER2-specific mAbs, trastuzumab and pertuzumab (T+P), combined with chemotherapy comprise standard-of-care treatment for advanced HER2+ breast cancers…”
Get full text

Key takeaways for knowledge expansion of early-career scientists conducting Transdisciplinary Research in Energetics and Cancer (TREC): a report from the TREC Training Workshop 2022 by Kung, Che-Pei, Skiba, Meghan B, Crosby, Erika J, Gorzelitz, Jessica, Kennedy, Mary A, Kerr, Bethany A, Li, Yun Rose, Nash, Sarah, Potiaumpai, Melanie, Kleckner, Amber S, James, Dara L, Coleman, Michael F, Fairman, Ciaran M, Galván, Gloria C, Garcia, David O, Gordon, Max J, His, Mathilde, Hornbuckle, Lyndsey M, Kim, So-Youn, Kim, Tae-Hyung, Kumar, Amanika, Mahé, Mélanie, McDonnell, Karen K, Moore, Jade, Oh, Sangphil, Sun, Xinghui, Irwin, Melinda L

“…The overall goal of the annual Transdisciplinary Research in Energetics and Cancer (TREC) Training Workshop is to provide transdisciplinary training for…”
Get full text

Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy by Ren, Jun, Gwin, William R., Zhou, Xinna, Wang, Xiaoli, Huang, Hongyan, Jiang, Ni, Zhou, Lei, Agarwal, Pankaj, Hobeika, Amy, Crosby, Erika, Hartman, Zachary C., Morse, Michael A., H. Eng, Kevin, Lyerly, H. Kim

“…Purpose: Although local oncolytic viral therapy (OVT) may enhance tumor lysis, antigen release, and adaptive immune responses, systemic antitumor responses…”
Get full text